Binding domain mutations provide insight into CTCF's relationship with chromatin and its contribution to gene regulation
- PMID: 40118069
- PMCID: PMC12008812
- DOI: 10.1016/j.xgen.2025.100813
Binding domain mutations provide insight into CTCF's relationship with chromatin and its contribution to gene regulation
Abstract
Here we used a series of CTCF mutations to explore CTCF's relationship with chromatin and its contribution to gene regulation. CTCF's impact depends on the genomic context of bound sites and the unique binding properties of WT and mutant CTCF proteins. Specifically, CTCF's signal strength is linked to changes in accessibility, and the ability to block cohesin is linked to its binding stability. Multivariate modeling reveals that both CTCF and accessibility contribute independently to cohesin binding and insulation, but CTCF signal strength has a stronger effect. CTCF and chromatin have a bidirectional relationship such that at CTCF sites, accessibility is reduced in a cohesin-dependent, mutant-specific fashion. In addition, each mutant alters TF binding and accessibility in an indirect manner, changes which impart the most influence on rewiring transcriptional networks and the cell's ability to differentiate. Collectively, the mutant perturbations provide a rich resource for determining CTCF's site-specific effects.
Keywords: CTCF; CTCF mutations; cancer; chromatin accessibility; chromatin organization; cohesin; gene regulation; neurological disorder; residence time.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Figures
Update of
-
Binding domain mutations provide insight into CTCF's relationship with chromatin and its contribution to gene regulation.bioRxiv [Preprint]. 2025 Feb 18:2024.01.11.575070. doi: 10.1101/2024.01.11.575070. bioRxiv. 2025. Update in: Cell Genom. 2025 Apr 9;5(4):100813. doi: 10.1016/j.xgen.2025.100813. PMID: 38370764 Free PMC article. Updated. Preprint.
-
Brain and cancer associated binding domain mutations provide insight into CTCF's relationship with chromatin and its ability to act as a chromatin organizer.Res Sq [Preprint]. 2024 Jul 19:rs.3.rs-4670379. doi: 10.21203/rs.3.rs-4670379/v1. Res Sq. 2024. Update in: Cell Genom. 2025 Apr 9;5(4):100813. doi: 10.1016/j.xgen.2025.100813. PMID: 39070636 Free PMC article. Updated. Preprint.
References
-
- Filippova G.N., Lindblom A., Meincke L.J., Klenova E.M., Neiman P.E., Collins S.J., Doggett N.A., Lobanenkov V.V. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Genes. Chromosomes. Cancer. 1998;22:26–36. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
